Table 2.
Comparison of mean and 95% confidence interval of DMFT score between Oral7® and salt-soda groups among head and neck cancer patients who underwent radiotherapy
| Mean (95% CI) | |||
|---|---|---|---|
|
| |||
| Baseline | Post-radiotherapy | 3 months post-radiotherapy | |
| Oral7® | 13.7 (6.7, 20.7) | 13.8 (6.7, 20.9) | 13.7 (6.7, 20.6) |
| Salt-soda | 13.7 (6.7, 20.7) | 15.2 (8.1, | 22.3) 16.8 (9.9, 23.8) |